Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer
about
CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse modelAkt3 is responsible for the survival and proliferation of embryonic stem cellsFollicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.Akt and phospholipase Cγ are involved in the regulation of growth and migration of MDA-MB-468 breast cancer and SW480 colon cancer cells when cultured with diabetogenic levels of glucose and insulin.Molecular pathogenesis and mechanisms of thyroid cancerAkt1 mediates neuronal differentiation in zebrafish via a reciprocal interaction with notch signalingOpposing functions of Akt isoforms in lung tumor initiation and progressionOrthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAFMouse models of follicular and papillary thyroid cancer progression.Mouse models of thyroid cancer: A 2015 update.Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.RCAN1-4 is a thyroid cancer growth and metastasis suppressor.Coupling of LETM1 up-regulation with oxidative phosphorylation and platelet-derived growth factor receptor signaling via YAP1 transactivationGenetics and epigenetics of sporadic thyroid cancer.BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models.Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia.mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression.
P2860
Q28271131-C9B3B27A-01FA-4AD0-BA85-82B188543131Q30491624-533DDD72-DA6A-49B1-83AC-7BA14E92AB00Q33569087-778925DA-0CC4-46B3-A3F3-A3F8DF67471BQ34255016-A7B1D9B8-1B21-49CC-A983-59A0EF821C67Q34329018-0F8B606C-6F5E-40B4-83FF-EF37B4E33A57Q34559260-26E00241-DB33-4B4D-B7A9-CF3B8BBC29B5Q35145125-7EB9CAD4-42A8-4505-A212-2122752E18F9Q35914464-F31D8C08-000B-4696-AB8F-04399B44C634Q35971896-2AF0915F-5197-45C5-893F-052049518358Q36405539-FA41279D-644D-463A-BA21-DA261368ABB0Q37460181-643F1269-AAAC-4B43-9DBC-05B05E0E2F99Q37677411-782ED579-2B8C-4B0E-BBF0-8324D6B66DE8Q37687063-6178208E-A3B1-4F90-B53D-B8D30E205129Q38128097-285085A7-65EF-4908-B4A1-0A488A1A2450Q38739375-CCEC4CEF-C6B8-4A98-BB5E-9BB7E734DC52Q38896410-1FF01A8E-F403-41AE-BDCC-B29178992B36Q46415253-A3394295-EF44-4FEE-80DF-893BFDA0BE8BQ53682892-99CC038C-FF30-43B5-80B6-5D2CA2DA4226
P2860
Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Akt1 deficiency delays tumor p ...... murine model of thyroid cancer
@ast
Akt1 deficiency delays tumor p ...... murine model of thyroid cancer
@en
type
label
Akt1 deficiency delays tumor p ...... murine model of thyroid cancer
@ast
Akt1 deficiency delays tumor p ...... murine model of thyroid cancer
@en
prefLabel
Akt1 deficiency delays tumor p ...... murine model of thyroid cancer
@ast
Akt1 deficiency delays tumor p ...... murine model of thyroid cancer
@en
P2093
P2860
P356
P1433
P1476
Akt1 deficiency delays tumor p ...... murine model of thyroid cancer
@en
P2093
D Jarjoura
K M La Perle
K Narahara
M D Ringel
S K McCarty
P2860
P2888
P304
P356
10.1038/ONC.2011.136
P407
P50
P577
2011-05-02T00:00:00Z